Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study

Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study

Submitted by admin on July 13, 2018 - 9:18am
Source: 
CP Wire
News Tags: 
Advaxis
axalimogene filolisbac
HPV head and neck cancer
cervical cancer
Headline: 
Advaxis Shares Jump After FDA Lifts Clinical Hold on Phase 1/2 Study
snippet: 
  • Shares up 38%+ in pre-market trading
  • Clinical Hold was issued on March 9, 2018
  • Axalimogene filolisbac has fast track designation for adjuvant therapy for high-risk locally advanced cervical cancer

Do Not Allow Advertisers to Use My Personal information